Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mignot

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cytotechnology|January 1, 1992
Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free mediumF Dhainaut, N Bihoreau, J L Meterreau, et al.
Cytotechnology|September 1, 1990
Production of recombinant Von Willebrand factor by CHO cells cultured in macroporous microcarriersG Mignot, T Faure, V Ganne, et al.
Therapie|September 1, 1986
[Allergic thrombopenia induced by heparin or pentosan polysulfate]J Bayle, R M Chichmanian, A Caramella, et al.
Annales D'Endocrinologie|April 19, 2008
Cancer is not just a disease of a tissue: it is a host disease. How to reactivate host defense against tumors using conventional therapies of cancer?L Apetoh, F Ghiringhelli, A Tesniere, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
Therapie|March 1, 1991
[Hypersensitivity to hypoglycemic sulfonylurea compounds. Are there cross-reactions?]R M Chichmanian, G Papasseudi, S Hieronimus, et al.
Therapie|February 10, 2000
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]J P Boissel, M Cucherat, W Li, et al.
Therapie|February 10, 2000
[Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy]J P Boissel, M Cucherat, G Chatellier, et al.
Therapie|September 29, 1999
[The problem of therapeutic efficacy indices. 2. Description of the indices]J P Boissel, M Buyse, M Cucherat, et al.
Therapie|July 8, 1999
[The problem of therapeutic efficacy indices. 1. Elements of the problem]J P Boissel, M Cucherat, F Gueyffier, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cytotechnology|January 1, 1992
Continuous production of large amounts of monoclonal immunoglobulins in hollow fibers using protein-free mediumF Dhainaut, N Bihoreau, J L Meterreau, et al.
Cytotechnology|September 1, 1990
Production of recombinant Von Willebrand factor by CHO cells cultured in macroporous microcarriersG Mignot, T Faure, V Ganne, et al.
Therapie|September 1, 1986
[Allergic thrombopenia induced by heparin or pentosan polysulfate]J Bayle, R M Chichmanian, A Caramella, et al.
Annales D'Endocrinologie|April 19, 2008
Cancer is not just a disease of a tissue: it is a host disease. How to reactivate host defense against tumors using conventional therapies of cancer?L Apetoh, F Ghiringhelli, A Tesniere, et al.
British Journal of Cancer|July 14, 2011
T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survivalS Ladoire, L Arnould, G Mignot, et al.
Therapie|March 1, 1991
[Hypersensitivity to hypoglycemic sulfonylurea compounds. Are there cross-reactions?]R M Chichmanian, G Papasseudi, S Hieronimus, et al.
Therapie|February 10, 2000
[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]J P Boissel, M Cucherat, W Li, et al.
Therapie|February 10, 2000
[Outline of the problem of indices of therapeutic efficacy. 4. Expression of efficacy when the underlying illness is incurable. Study Group for the Indices of Efficacy]J P Boissel, M Cucherat, G Chatellier, et al.
Therapie|September 29, 1999
[The problem of therapeutic efficacy indices. 2. Description of the indices]J P Boissel, M Buyse, M Cucherat, et al.
Therapie|July 8, 1999
[The problem of therapeutic efficacy indices. 1. Elements of the problem]J P Boissel, M Cucherat, F Gueyffier, et al.
Pageof 5